Clinical Trials Logo

Heart Disease in Women clinical trials

View clinical trials related to Heart Disease in Women.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03949829 Active, not recruiting - Clinical trials for Cardiovascular Diseases

The CoPenHagen PREeClampsia and cardIOvascUlar diSease Study

CPH-PRECIOUS
Start date: May 20, 2019
Phase:
Study type: Observational [Patient Registry]

Women with a history of preeclampsia (PE) have increased risk of hypertension and cardiovascular disease (CVD) later in life. Thus, PE is acknowledged as an independent risk factor for CVD, which is the number one cause of death in women in the western part of the world. Objective: The purpose of this study is to investigate 1) the prevalence of CVD after PE, 2) which women have the highest risk of developing CVD, 3) when early stages of CVD can be detected in women with previous PE and 4) how CVD progress over time. Methods: 1000 women with previous PE between the age of 35-55 years will be invited to participate in a follow-up study consisting of anthropometric measurements, blood pressure measurement, urine- and blood samples, cardiac CT-scan and questionnaires. Coronary atherosclerosis will be evaluated using CT imaging.The women will be compared with women with a formerly uncomplicated pregnancy, Summary: The study will provide new important information to guide future clinical follow-up, and potentially prevent disease and early death in a large group of women with a history of PE.